Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
This intro explains what a high index level may indicate in terms of trend strength, momentum, and potential market overheating.
25,925 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
The stock market live march update shows the S&P 500 slipping as a Trump deadline extension adds uncertainty. Traders...
Bitcoin edges toward the $60,000 threshold as a $14 billion liquidation risk gathers in the futures market, threateni...
As policy changes from lenders and the GSEs take shape, mortgage markets face a potential major shift in credit alloc...
Microsoft Copilot AI signals a bold XRP rally by year-end 2026, driven by real-world catalysts and on-chain activity....
Former President Donald Trump pledges to release government records on aliens and UAPs, sparking a debate about trans...
Starting with $1,000, you can build a durable energy stock portfolio. This guide shows the smartest energy stocks wit...
Former President Donald Trump publicly supports CFTC Chair Michael Selig's push to widen federal control over predict...
Bitcoin slides to $62K as the broader market weakens, but long bets rise in response, complicating the bitcoin price ...
IBM’s dramatic one-day plunge coincided with blockbuster bank profits, fueling a debate over whether markets are misp...
Artificial intelligence is reshaping markets, but one big risk many investors fear may be overblown. This article exp...
The MLS/CLAW announces a sweeping tweak to its IDX policy and will add Compass’s full active listings, aiming to boos...